Bioventus Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	251	415	203	1,090	-	-	-
Market Cap Growth	-	104.55%	-81.39%	-	-	-	-
Enterprise Value	609	773	591	1,398	102	133	152
PE Ratio	-2.66	-2.66	-1.28	56.26	-	-	-
PS Ratio	0.49	0.81	0.40	2.53	-	-	-
PB Ratio	1.45	2.39	0.62	2.38	-	-	-
P/FCF Ratio	31.44	52.00	-8.61	115.09	-	-	-
P/OCF Ratio	16.36	27.05	-14.99	47.41	-	-	-
EV/Sales Ratio	1.19	1.51	1.15	3.25	0.32	0.39	0.48
EV/EBITDA Ratio	-13.30	-13.30	-4.35	26.19	1.81	2.21	4.02
EV/EBIT Ratio	-6.69	-6.69	-3.09	75.51	3.71	4.45	17.62
EV/FCF Ratio	76.28	96.83	-25.06	147.66	1.84	3.48	3.57
Debt / Equity Ratio	2.27	2.27	1.29	0.78	1.31	1.38	1.34
Debt / EBITDA Ratio	-6.80	-6.80	-3.08	6.70	3.36	3.28	5.15
Debt / FCF Ratio	49.47	49.47	-17.73	37.77	3.41	5.16	4.57
Quick Ratio	0.91	0.91	0.55	0.96	1.43	1.68	1.76
Current Ratio	1.53	1.53	0.90	1.46	1.73	2.06	2.27
Asset Turnover	0.61	0.61	0.40	0.54	0.66	0.74	-
Interest Coverage	-2.84	-2.84	-15.89	16.66	2.81	1.39	0.45
Return on Equity (ROE)	-86.50%	-86.50%	-40.50%	8.70%	11.40%	4.80%	-
Return on Assets (ROA)	-18.70%	-18.70%	-12.30%	2.40%	3.40%	1.50%	-
Return on Capital (ROIC)	-21.18%	-21.18%	-25.28%	1.41%	4.46%	2.31%	1.58%
Earnings Yield	-62.25%	-37.64%	-78.22%	1.78%	-	-	-
FCF Yield	3.18%	1.92%	-11.62%	0.87%	-	-	-
Buyback Yield / Dilution	-2.05%	-2.05%	-35.00%	-828.01%	-	-	-
Total Shareholder Return	-2.05%	-2.05%	-35.00%	-828.01%	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).